Novel composition for treatment of essential thrombocythemia

Details for Australian Patent Application No. 2009324043 (hide)

Owner AOP Orphan Pharmaceuticals AG

Inventors Widmann, Rudolf

Agent Davies Collison Cave

Pub. Number AU-A-2009324043

PCT Pub. Number WO2010/063824

Priority GM707/2008 05.12.08 AT

Filing date 4 December 2009

Wipo publication date 10 June 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/60 (2006.01) - Salicylic acid

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

Event Publications

16 June 2011 PCT application entered the National Phase

  PCT publication WO2010/063824 Priority application(s): WO2010/063824

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009324052-Plant growth promoting protein complex

2009324042-Method for producing platelets